TrialStroke and vascular neurology2026

Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial.

Shuya Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.